# Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

> **NCT04856774** · PHASE1,PHASE2 · COMPLETED · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 81 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** SHR-1701；BP102

## Key facts

- **NCT ID:** NCT04856774
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856774, "Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04856774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*